How Much of That Pinch Will Consumers Feel?
One thing is certain: How much, if any, of the boosted costs are passed on to consumers will depend on their health coverage.
Medicare beneficiaries, those enrolled in Medicaid — the state-federal health insurance program for people with low incomes — and people with Affordable Care Act coverage will continue to get covid vaccines without cost sharing, even when the public health emergency ends and the government-purchased vaccines run out. Many people with job-based insurance will also likely not face copayments for vaccines, unless they go out of network for their vaccinations. People with limited-benefit or short-term insurance policies might have to pay for all or part of their vaccinations. And people who don’t have insurance will need to either pay the full cost out-of-pocket or seek no- or low-cost vaccinations from community clinics or other providers. If they cannot find a free or low-cost option, some uninsured patients may be forced to skip vaccinations or testing.
Coming up with what could be $100 or more for vaccination will be especially hard “if you are uninsured or underinsured; that’s where these price hikes could drive additional disparities,” said Sean Robbins, executive vice president of external affairs for the Blue Cross Blue Shield Association. Those increases, he said, will also affect people with insurance, as the costs “flow through to premiums.”
Meanwhile, public policy experts say many private insurers will continue to cover Paxlovid, although patients may face a copayment, at least until they meet their deductible, just as they do for other medications. Medicaid will continue to cover it without cost to patients until at least 2024. But Medicare coverage will be limited until the treatment goes through the regular FDA process, which takes longer than the emergency use authorization it has been marketed under.
Another complication: The rolls of the uninsured are likely to climb over the next year, as states are poised to reinstate the process of regularly determining Medicaid eligibility, which was halted during the pandemic. Starting in April, states will begin reassessing whether Medicaid enrollees meet income and other qualifying factors.
An estimated 5 million to 14 million people nationwide might lose coverage.
“This is our No. 1 concern” right now, said John Baackes, CEO of L.A. Care, the nation’s largest publicly operated health plan with 2.7 million members.
“They may not realize they’ve lost coverage until they go to fill a prescription” or seek other medical care, including vaccinations, he said.
More Articles
- Medical Billing and Collections Among Older Americans
- Congressional Budget Office: Federal Budget Deficit Totals $1.4 Trillion in 2023; Annual Deficits Average $2.0 Trillion Over the 2024–2033 Period
- Center for Strategic and International Studies: “The Future Outlook with Dr. Anthony Fauci”
- Kaiser Family Foundation (KFF): Over 200,000 Residents and Staff in Long-Term Care Facilities Have Died From COVID-19
- Kaiser Health News (KHN): Colleges and Universities Plan for Normal-ish Campus Life in the Fall
- Jill Norgren Reviews The Doctor's Blackwell: How Two Pioneering Sisters Brought Medicine to Women — and Women to Medicine
- *KFF: Gaps in Cost Sharing Protections for COVID-19 Testing and Treatment Could Spark Public Concerns About COVID-19 Vaccine Costs
- Stateline, Biden Likely to Help States Increase Health Care Access: December 15, 2020, Last Day to Enroll In or Change Plans for 2021 Coverage and GAO Reports on Breast and Cervical Cancer.
- Kaiser Health Foundation: Distributing a COVID-19 Vaccine Across the U.S. - A Look at Key Issues
- Federal Reserve: Optimism in the Time of COVID; Businesses Seem Much Better Adapted to Remaining Open
